XML 90 R73.htm IDEA: XBRL DOCUMENT v3.25.0.1
Stock Compensation - Narrative (Details) - USD ($)
$ / shares in Units, $ in Millions
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Stock based Compensation      
Number of shares authorized (in shares) 5,925,000    
Number of shares authorized, remaining (in shares) 4,446,532    
Class C Restricted Interests      
Stock based Compensation      
Award vesting period 5 years    
Fair value of vested shares   $ 0.7 $ 0.7
Stock compensation expense   $ 0.1 $ 0.7
Class C Restricted Options      
Stock based Compensation      
Exercise of stock options, weighted average exercise price (in dollars per share)   $ 1.18 $ 1.18
Restricted stock awards      
Stock based Compensation      
Award vesting period 4 years    
Stock compensation expense $ 0.9    
Restricted stock awards | Select Medical Corporation      
Stock based Compensation      
Stock compensation expense $ 1.5 $ 0.5  
Employee Stock Option      
Stock based Compensation      
Award vesting period 5 years    
Award expiration term 10 years    
Class C Options      
Stock based Compensation      
Stock compensation expense   $ 0.1 $ 1.5
Exercise of stock options, weighted average exercise price (in dollars per share)   $ 2.66 $ 2.66
Total intrinsic value of options exercised   $ 6.3 $ 5.9
Stock options granted during period (in shares) 0 0 0
Class B Options      
Stock based Compensation      
Stock options granted during period (in shares) 0 0 0